Literature DB >> 24001033

Septal perforation and bilateral partial middle turbinate necrosis after bilateral sphenopalatine artery ligation.

E Elsheikh1, M W El-Anwar.   

Abstract

OBJECTIVE: To report previously unreported complications of bilateral sphenopalatine artery ligation. SUBJECTS AND METHODS: We present the case of a 45-year-old man who underwent bilateral sphenopalatine artery ligation to control intractable posterior epistaxis. After four months, he re-presented with nasal obstruction and crusting. RESULTS AND ANALYSIS: Examination under general anaesthesia showed posterior septal perforation and bilateral necrosis of the lower parts of the middle turbinates. The necrotic parts were excised. The patient had no more complaints.
CONCLUSION: Following sphenopalatine artery occlusion, ischaemic necrosis is a potential risk in anatomical areas that receive their only arterial supply from this artery. The staging of bilateral sphenopalatine artery occlusion needs to be studied.

Entities:  

Mesh:

Year:  2013        PMID: 24001033     DOI: 10.1017/S0022215113001904

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  4 in total

Review 1.  Comprehensive review on endonasal endoscopic sinus surgery.

Authors:  Rainer K Weber; Werner Hosemann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

2.  Role of Endoscopic Internal Maxillary Artery Ligation in Intractable Idiopathic Epistaxis.

Authors:  Vivek Sasindran; Mithra Sara John
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-01-08

3.  Treatment of sphenopalatine artery bleeding.

Authors:  Zhengcai Lou; Zi-Han Lou
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-10-09       Impact factor: 2.503

4.  Endoscopic Sphenopalatine Artery Ligation in Posterior Epistaxis: Retrospective Analysis of 30 Patients.

Authors:  Onur İsmi; Yusuf Vayisoğlu; Cengiz Özcan; Kemal Görür; Murat Ünal
Journal:  Turk Arch Otorhinolaryngol       Date:  2016-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.